Atlas Trials

Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer

Clinical trial NCT00268411 · UNKNOWN

Trial details

NCT number
NCT00268411
Sponsor
GERCOR - Multidisciplinary Oncology Cooperative Group
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2004-09-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.